A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT04123795 · COMPLETED

Trial details

NCT number: NCT04123795
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate Chronic Plaque Psoriasis Severe Chronic Plaque Psoriasis Mixed Guttate/Plaque Psoriasis

Start date: 2020-01-21
Primary completion: 2026-04-09
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.